Home > Insider Trading > Filing (0001213900-21-029080)

Filing Details

Accession Number:: 0001213900-21-029080
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-05-25 16:46:19
Reporting Period:: 2021-05-21

Accepted Time:: 2021-05-25 16:46:19
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1410098	Cormedix Inc.	CRMD	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1735256	Elizabeth Masson-Hurlburt	C/O Cormedix Inc., 300 Connell Drive, Suite 4200 Berkeley Heights NJ 07922	Evp, Head Of Clinical Ops	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-05-21	8,000	$6.92	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (Right to Buy Common Stock)	$8.32	2031-01-11	140,000	140,000	Direct
Common Stock	Stock Option (Right to Buy Common Stock)	$5.63	2030-05-11	37,500	37,500	Direct
Common Stock	Stock Option (Right to Buy Common Stock)	$4.08	2030-05-11	37,500	37,500	Direct
Common Stock	Stock Option (Right to Buy Common Stock)	$5.63	2030-02-25	24,764	24,764	Direct
Common Stock	Stock Option (Right to Buy Common Stock)	$8.30	2029-01-10	20,880	20,880	Direct
Common Stock	Stock Option (Right to Buy Common Stock)	$1.45	2028-03-19	54,000	54,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2031-01-11	140,000	140,000	Direct
2030-05-11	37,500	37,500	Direct
2030-05-11	37,500	37,500	Direct
2030-02-25	24,764	24,764	Direct
2029-01-10	20,880	20,880	Direct
2028-03-19	54,000	54,000	Direct

Footnotes

This transaction was executed in multiple trades at prices ranging from $6.665 to $6.97. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
These options were granted on 1/11/2021. These options vest, subject to continued employment, as follows: 50% of the options vest over time, with 25% vested on the grant date and 25% vesting in equal thirds on the first, second and third anniversaries of the grant date; and 50% of the options vest upon the achievement of certain milestones.
These options were granted on 05/11/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
These options were granted on 02/25/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
These options were granted on 1/10/2019. These options vest, subject to continued employment, as follows: 35% of the options vest over time, with 25% vested on the grant date and 25% vesting on the first, second and third anniversaries of the grant date; and 65% of the options vest upon the achievement of certain milestones. These options include options to purchase 2,100 shares that are subject to vesting each on January 10, 2021 and January 10, 2022.
The options vest as follows: 37,200 will vest over four years in four (4) equal installments on the first four anniversaries of 3/19/2018. The remaining options vest on the achievement of certain milestones, subject to continued employment.